Revance Therapeutics Inc (RVNC)

[stocksrising]

Yes, I recall ID web and your message, thanks for refresher :)( this specifically was ‘operating’ I get it…*~$585mm updated high end

Let’s see SG&A from Q3 when released.
Q2** showed ~64% increase over Q2( 2022) and I realize they added (employees) sales/ Marketing, other but with roughly $315mm cash +$50mm note, burn in 2024* will no doubt cause need for raise***( as perhaps expected, but with share price 2/3 lower, major dilution unless we recover next year)!

** Selling, general and administrative
77,384 Q2-2023
47,847 Q2-2022

***excludes any potential collaboration with Therapeutic partner
Again, grasping at straws of frustration, it helps my anxiety by lashing out at Mgmt!!